HYDROMORPHONE Side Effects

6647588-8 | Unresponsive To Stimuli
on Mar 23, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: unresponsive to stimuli. Hydromorphone dosage: 2 Mg Once Sq.

6554019-5 | Phantom Pain
Patient was taking Hydromorphone (View Usage). Patient had the following side effects: phantom pain on Jan 22, 2010 from Additional patient health information: Male patient , 21 years of age, weighting 101.4 lb, was diagnosed with phantom pain, breakthrough pain, transfusion and. Hydromorphone dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMITRIPTYLINE HCL (50 Mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), DIPHENHYDRAMINE (50 Mg) (View Diphenhydramine Review and Diphenhydramine Label ), PLATELETS (225 Ml) (View Platelets Review and Platelets Label ), RED BLOOD CELLS (207 Ml) (View Red Blood Cells Review and Red Blood Cells Label ).

6542342-X | Asthenia, Contusion, Headache, Nausea, Pruritus, Scar, Scratch, Skin Haemorrhage, Somnolence
Adverse event was reported on May 29, 2009 by a Female patient taking Hydromorphone (View Usage) (Dosage: 1 Tab Q 4-6 Hrs, Prn) was diagnosed with pain (What is pain?), depression (What is depression?), hypothyroidism, blood triglycerides increased, gastrooesophageal reflux disease and. Location: UNITED STATES , 53 years of age, weighting 123.0 lb, After Hydromorphone was administered, patient had the following side effects: asthenia, contusion, headache (What is headache?), nausea (What is nausea?), pruritus, scar (What is scar?), scratch, skin haemorrhage, somnolence. During the same period patient was treated with EFFEXOR (2 In Am 2 In Pm) (View Effexor Review and Effexor Label ), LEVOTHYROXINE SODIUM (125 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), RANITIDINE (300 Mg, Qd (qhs)) (View Ranitidine Review and Ranitidine Label ).

6542340-6 | Dizziness, Vision Blurred
on Nov 04, 2009 Female patient from UNITED STATES , 54 years of age, was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), vision blurred. Hydromorphone dosage: .


6503562-3 | Bradycardia, Chronic Obstructive Pulmonary Disease, Delirium, Lobar Pneumonia, Respiratory Arrest
on Dec 02, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). Patient had the following side effects: bradycardia, chronic obstructive pulmonary disease, delirium, lobar pneumonia, respiratory arrest. Hydromorphone dosage: Unk. During the same period patient was treated with CARDIZEM (120 Mg, Qd) (View Cardizem Review and Cardizem Label ), COUMADIN (2.5 Mg, Qd) (View Coumadin Review and Coumadin Label ), DIGOXIN /00545901/ (0.125 Mg, Qd) (View Digoxin /00545901/ Review and Digoxin /00545901/ Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DIAZEPAM (5 Mg, Bid) (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6493341-8 | Aspiration, Device Computer Issue, Overdose, Respiratory Arrest
Patient was taking Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: aspiration, device computer issue, overdose, respiratory arrest on Nov 26, 2009 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with pain (What is pain?) and. Hydromorphone dosage: .75 Mg, Intrathecal. During the same period patient was treated with BUPIVACAINE (.9 Mg, Intrathecal) (View Bupivacaine Review and Bupivacaine Label ).

6381945-2 | Overdose
Adverse event was reported on Jul 02, 2009 by a Male patient taking Hydromorphone (View Usage) (Dosage: 3 Injections In 9 Hours) was diagnosed with oropharyngeal pain and. Location: UNITED STATES , 40 years of age, Patient experienced the following unwanted or unexpected effects: overdose.

6379300-4 | Infusion Related Reaction, Nausea, Retching
on Sep 23, 2009 Male patient from UNITED STATES , 19 years of age, weighting 158.7 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). Patient had the following side effects: infusion related reaction, nausea (What is nausea?), retching. Hydromorphone dosage: Var Dose 0.5 - 1mg; 1mg/hr Iv. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), INSULIN (View Insulin Review and Insulin Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PROPOFOL (View Propofol Review and Propofol Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6379299-0 | Blood Pressure Decreased, Mental Status Changes, Respiratory Rate Decreased
on Sep 23, 2009 Male patient from UNITED STATES , 72 years of age, weighting 233.7 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: blood pressure decreased, mental status changes, respiratory rate decreased. Hydromorphone dosage: 0/0.4/10 Pca Prn. During the same period patient was treated with DOCUSATE (View Docusate Review and Docusate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), INSULIN (View Insulin Review and Insulin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NADDOL (View Naddol Review and Naddol Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6379095-4 | Blood Lactic Acid Increased, Dysphagia, Hypercapnia, Lethargy, Pain, Pyrexia, Respiratory Rate Decreased, Staphylococcal Bacteraemia
Patient was taking Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, dysphagia, hypercapnia, lethargy, pain (What is pain?), pyrexia, respiratory rate decreased, staphylococcal bacteraemia on Sep 23, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 176.4 lb, was diagnosed with pain (What is pain?) and. Hydromorphone dosage: 3mg Iv Total. During the same period patient was treated with ATOVAQUONE (View Atovaquone Review and Atovaquone Label ), PEPTO BISMOL (View Pepto Bismol Review and Pepto Bismol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6377595-4 | Creatinine Renal Clearance Decreased, Sedation
Adverse event was reported on Sep 23, 2009 by a Male patient taking Hydromorphone (View Usage) (Dosage: 0/0.4/10 Pca) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 65 years of age, weighting 202.8 lb, Patient had the following side effects: creatinine renal clearance decreased, sedation. During the same period patient was treated with MONKELLUKAST (View Monkellukast Review and Monkellukast Label ), NANITIDINE (View Nanitidine Review and Nanitidine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), EPO (View Epo Review and Epo Label ), INSULIN (View Insulin Review and Insulin Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), MILVINONE (View Milvinone Review and Milvinone Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ).

6377593-0 | Somnolence
on Sep 23, 2009 Female patient from UNITED STATES , 60 years of age, weighting 135.6 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: somnolence. Hydromorphone dosage: 4mg, Q3h, Po Prior To 6/13/09. During the same period patient was treated with DIPHENHYCLRAMINE (View Diphenhyclramine Review and Diphenhyclramine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DOCUSATE (View Docusate Review and Docusate Label ), SENNA (View Senna Review and Senna Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6377432-8 | Somnolence
on Sep 23, 2009 Male patient from UNITED STATES , 69 years of age, weighting 270.1 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence. Hydromorphone dosage: 4mg Po Q3h. During the same period patient was treated with LACTOBACILLUS (View Lactobacillus Review and Lactobacillus Label ), XALATAN (View Xalatan Review and Xalatan Label ), MIRALAX (View Miralax Review and Miralax Label ), TIMOLOL (View Timolol Review and Timolol Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6377349-9 | Lethargy
Patient was taking Hydromorphone (View Usage). Patient had the following side effects: lethargy on Sep 23, 2009 from UNITED STATES Additional patient health information: Female patient , 85 years of age, weighting 167.6 lb, was diagnosed with pain (What is pain?) and. Hydromorphone dosage: 0/0.2/10 Pca. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), LEVOFLOX (View Levoflox Review and Levoflox Label ).

6377323-2 | Respiration Abnormal
Adverse event was reported on Sep 23, 2009 by a Female patient taking Hydromorphone (View Usage) (Dosage: 0/0, 2/10 Iv Pca ; 0.2 Mg Iv X 1) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 75 years of age, weighting 134.5 lb, After Hydromorphone was administered, patient had the following side effects: respiration abnormal. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), INSULIN (View Insulin Review and Insulin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ).

6367835-X | Meningococcal Infection
on Sep 16, 2009 Female patient from UNITED STATES , 19 years of age, was diagnosed with analgesia, systemic lupus erythematosus and was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: meningococcal infection. Hydromorphone dosage: Unk. During the same period patient was treated with CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ).

6248701-7 | Arthralgia, Carpal Tunnel Syndrome, Musculoskeletal Pain, Neck Pain, Therapeutic Response Unexpected
on Apr 20, 2009 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with abdominal discomfort, malaise and was treated with Hydromorphone (View Usage). Patient had the following side effects: arthralgia, carpal tunnel syndrome (What is carpal tunnel syndrome?), musculoskeletal pain, neck pain, therapeutic response unexpected. Hydromorphone dosage: 2 Mg, Tid. During the same period patient was treated with DILAUDID (2 Mg, Tid) (View Dilaudid Review and Dilaudid Label ), FENTANYL 100 (25 Ug (mcg), Hr, Td) (View Fentanyl-100 Review and Fentanyl-100 Label ).

6247868-4 | Dizziness, Dysarthria
Patient was taking Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: dizziness (What is dizziness?), dysarthria on Mar 31, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 162.0 lb, was diagnosed with wound complication, pain (What is pain?), depression (What is depression?), irritable bowel syndrome (What is irritable bowel syndrome?), glaucoma (What is glaucoma?), blood pressure (What is blood pressure?), gastrooesophageal reflux disease and. Hydromorphone dosage: 1 Mg (1/2 A Tablet), Qd. During the same period patient was treated with LEXAPRO (10 Mg, Qd) (View Lexapro Review and Lexapro Label ), AMITIZA (8 Mg, Qd) (View Amitiza Review and Amitiza Label ), TRAVATAN (Unk) (View Travatan Review and Travatan Label ), AVAPRO (Unk) (View Avapro Review and Avapro Label ), PREVACID (30 Mg, Qd) (View Prevacid Review and Prevacid Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (1/2 Tab Q1-2x Prn) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

5147506-8 | Cardiac Arrest, Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Oct 30, 2006 by a Female patient taking Hydromorphone (View Usage) (Dosage: Ingestion) . Location: UNITED STATES , 26 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, completed suicide. During the same period patient was treated with ETHANOL (Ingestion) (View Ethanol Review and Ethanol Label ).

5011173-4 | Blood Pressure Immeasurable, Blood Pressure Systolic Increased, Cardio-respiratory Arrest, Loss Of Consciousness, Post Procedural Complication, Respiratory Rate Increased, Snoring, Somnolence
on May 23, 2006 Male patient from UNITED STATES , 68 years of age, was diagnosed with procedural pain and was treated with Hydromorphone (View Usage). Patient had the following side effects: blood pressure immeasurable, blood pressure systolic increased, cardio-respiratory arrest, loss of consciousness, post procedural complication, respiratory rate increased, snoring (What is snoring?), somnolence. Hydromorphone dosage: Iv. During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ).

5010920-5 | Cardio-respiratory Arrest, Loss Of Consciousness, Respiratory Rate Increased
on May 23, 2006 Female patient from UNITED STATES , 52 years of age, weighting 200.6 lb, was treated with Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: cardio-respiratory arrest, loss of consciousness, respiratory rate increased. Hydromorphone dosage: 1mg X 3 Iv, Pca.

5010916-3 | Apnoea, Bradycardia, Pneumonia Aspiration
Patient was taking Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, bradycardia, pneumonia aspiration on May 23, 2006 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with pain (What is pain?), pancreatitis and. Hydromorphone dosage: Pca. During the same period patient was treated with FENTANYL (Top) (View Fentanyl Review and Fentanyl Label ).

4947902-5 | Cardio-respiratory Arrest, Loss Of Consciousness
Adverse event was reported on Mar 17, 2006 by a Female patient taking Hydromorphone (View Usage) (Dosage: 2 Mg One Time Iv) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 78 years of age, Patient had the following side effects: cardio-respiratory arrest, loss of consciousness.

4830154-4 | Apnoea, Cardio-respiratory Arrest, Chest Pain, Depressed Level Of Consciousness, Epistaxis, Feeling Hot, Vomiting
on Nov 15, 2005 Female patient from UNITED STATES , 49 years of age, weighting 264.6 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: apnoea, cardio-respiratory arrest, chest pain (What is chest pain?), depressed level of consciousness, epistaxis, feeling hot, vomiting. Hydromorphone dosage: 2 Mg Im. During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4828131-2 | Apnoea, Cardio-respiratory Arrest, Chest Pain, Depressed Level Of Consciousness, Epistaxis, Feeling Hot, Vomiting
on Nov 14, 2005 Female patient from UNITED STATES , 49 years of age, weighting 264.6 lb, was diagnosed with pain (What is pain?) and was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, cardio-respiratory arrest, chest pain (What is chest pain?), depressed level of consciousness, epistaxis, feeling hot, vomiting. Hydromorphone dosage: 2mg Im. During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4825951-5 | Delirium
Patient was taking Hydromorphone (View Usage). Patient had the following side effects: delirium on Nov 10, 2005 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 196.2 lb, was diagnosed with back pain (What is back pain?), nausea (What is nausea?) and. Hydromorphone dosage: 2mg Iv Q4h Prn. During the same period patient was treated with PROMETHAZINE (25mg/ 1mliv) (View Promethazine Review and Promethazine Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), QUININE (View Quinine Review and Quinine Label ). Patient was hospitalized.

4806798-2 | Respiratory Arrest
Adverse event was reported on Oct 21, 2005 by a Female patient taking Hydromorphone (View Usage) (Dosage: Injectable) . Location: UNITED STATES , 32 years of age, After Hydromorphone was administered, patient had the following side effects: respiratory arrest.

4805166-7 | Completed Suicide
on Oct 10, 2005 Female patient from UNITED STATES , 54 years of age, was treated with Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Hydromorphone dosage: Not Reported. During the same period patient was treated with OXYCODONE HCL (Long-acting) (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

4805160-6 | Overdose
on Oct 10, 2005 Female patient from UNITED STATES , 40 years of age, was treated with Hydromorphone (View Usage). Patient had the following side effects: overdose. Hydromorphone dosage: Not Reported. During the same period patient was treated with ALPRAZOLAM (Not Reported) (View Alprazolam Review and Alprazolam Label ).

4798067-4 | Rash Maculo-papular
Patient was taking Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: rash maculo-papular on Oct 06, 2005 from UNITED STATES Additional patient health information: Male patient , 19 years of age, weighting 235.0 lb, was diagnosed with pain (What is pain?) and. Hydromorphone dosage: See Image. During the same period patient was treated with KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MORPHINE (View Morphine Review and Morphine Label ), HEPARIN (View Heparin Review and Heparin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

4725712-1 | Hypotension, Incoherent, Incorrect Dose Administered, Malaise, Mental Status Changes, Tremor
Adverse event was reported on Jul 22, 2005 by a Male patient taking Hydromorphone (View Usage) (Dosage: 8mg Qd Oral) . Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: hypotension, incoherent, incorrect dose administered, malaise, mental status changes, tremor. Patient was hospitalized.

4725591-2 | Respiratory Depression
on Jul 22, 2005 Female patient from UNITED STATES , 59 years of age, was treated with Hydromorphone (View Usage). Patient had the following side effects: respiratory depression. Hydromorphone dosage: 2mg Intravenou.

4631150-2 | Dyspnoea, Hypoxia, Respiratory Rate Decreased, Somnolence
on Apr 07, 2005 Female patient from , 40 years of age, weighting 213.8 lb, was treated with Hydromorphone (View Usage). After Hydromorphone was administered, patient had the following side effects: dyspnoea, hypoxia, respiratory rate decreased, somnolence. Hydromorphone dosage: 3.2 Intravenou. Patient was hospitalized.

4625599-1 | Cardio-respiratory Arrest, Sleep Apnoea Syndrome
Patient was taking Hydromorphone (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, sleep apnoea syndrome on Mar 31, 2005 from Additional patient health information: Female patient , 34 years of age, weighting 386.2 lb, was diagnosed with post procedural pain and. Hydromorphone dosage: Intravenous. During the same period patient was treated with FENTANYL (Intravenous) (View Fentanyl Review and Fentanyl Label ).

4588629-1 | Depressed Level Of Consciousness, Pruritus, Respiratory Depression, Sedation
Adverse event was reported on Feb 14, 2005 by a Female patient taking Hydromorphone (View Usage) (Dosage: 6 Mg Iv Over 5 Hrs) was diagnosed with migraine (What is migraine?), pain (What is pain?) and. Location: , 47 years of age, weighting 138.0 lb, Patient had the following side effects: depressed level of consciousness, pruritus, respiratory depression, sedation. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), SKELAXIN (View Skelaxin Review and Skelaxin Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TORADOL (View Toradol Review and Toradol Label ). Patient was hospitalized.